Schistosoma mansoni ‐related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters

One thousand six hundred and ninety‐five inhabitants of 3 rural villages on Ukerewe Island, Lake Victoria, Tanzania, were examined by clinical, parasitological, ultrasonographic and—in part—serological means to evaluate Schistosoma (S.) mansoni‐related morbidity on a community level. Villagers frequently complained of typical colitis symptoms (abdominal pain 80.1%, bloody stools 43.1%, diarrhoea 35.1%); haematemesis, on the other hand, was rare (and reports doubtful in most cases). 16.9% of the population had been given praziquantel previously. Overall S. mansoni prevalence was 86.3%, with a median egg output of 176 eggs per gram (e.p.g.) and a maximum output of 17 984 e.p.g. Children and adolescents were infected more severely than adults, men more severely than women. Pretreated individuals excreted significantly fewer ova (median 124 vs 192e.p.g., P<0.001).

[1]  Y. Yazdanpanah,et al.  Ultrasonography in a Senegalese community recently exposed to Schistosoma mansoni infection. , 1996, The American journal of tropical medicine and hygiene.

[2]  E. Doehring-Schwerdtfeger,et al.  Ultrasonography in schistosomiasis in Africa. , 1995, Memorias do Instituto Oswaldo Cruz.

[3]  H. Traoré,et al.  Lack of ultrasonographic evidence for severe hepatosplenic morbidity in schistosomiasis mansoni in Mali. , 1994, The American journal of tropical medicine and hygiene.

[4]  R. Davidson,et al.  Use of ultrasound in a study of schistosomal periportal fibrosis in rural Zimbabwe. , 1993, Acta tropica.

[5]  J. Ehrich,et al.  Ultrasound versus clinical examination as indication for Schistosoma mansoni associated morbidity in children. , 1992, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[6]  J. Richter,et al.  Hepatosplenic schistosomiasis: comparison of sonographic findings in Brazilian and Sudanese patients--correlation of sonographic findings with clinical symptoms. , 1992, Radiology.

[7]  B. Gryseels Morbidity due to infection with Schistosoma mansoni: an update. , 1992, Tropical and geographical medicine.

[8]  C. Hatz,et al.  A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 3. Schistosoma japonicum. , 1992, Acta tropica.

[9]  M. Tanner,et al.  Ultrasound in schistosomiasis--a critical look at methodological issues and potential applications. , 1992, Acta tropica.

[10]  C. Kaiser,et al.  Inter-observer variance in ultrasonographical assessment of Schistosoma mansoni-related morbidity in young schoolchildren. , 1992, Acta tropica.

[11]  D. Schuppan,et al.  Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease , 1992, Hepatology.

[12]  J. Ehrich,et al.  Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity twenty-three months after treatment with praziquantel. , 1992, The American journal of tropical medicine and hygiene.

[13]  M. Tanner,et al.  A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni. , 1992, Acta tropica.

[14]  R. Morrow,et al.  The use of diagnostic ultrasound in schistosomiasis--attempts at standardization of methodology. Cairo Working Group. , 1992, Acta tropica.

[15]  B. Blas,et al.  Ultrasonographic and serologic abnormalities in Schistosoma japonicum infection in Leyte, the Philippines. , 1992, The American journal of tropical medicine and hygiene.

[16]  T. Nash,et al.  Oesophageal varices in a region of the Sudan endemic for Schistosoma mansoni , 1991, The British journal of surgery.

[17]  T. Nash,et al.  Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. , 1991, The American journal of tropical medicine and hygiene.

[18]  R. Davidson,et al.  Schistosomal periportal fibrosis in Zimbabwe: use of ultrasound in patients with oesophageal varices. , 1991, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  Gressner Am Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. , 1991 .

[20]  C. Kaiser,et al.  Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: reversibility of morbidity seven months after treatment with praziquantel. , 1991, The American journal of tropical medicine and hygiene.

[21]  A. Gressner Liver fibrosis: perspectives in pathobiochemical research and clinical outlook. , 1991, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[22]  D. Schuppan,et al.  Connective tissue polypeptides in serum as parameters to monitor antifibrotic treatment in hepatic fibrogenesis. , 1991, Journal of hepatology.

[23]  A. Steiner,et al.  Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy. , 1990, Annals of tropical medicine and parasitology.

[24]  J. Ehrich,et al.  Ultrasonographical investigation of periportal fibrosis in children with Schistosoma mansoni infection: evaluation of morbidity. , 1990, The American journal of tropical medicine and hygiene.

[25]  J. Richter,et al.  Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  J. Struewing,et al.  Sonographic studies of schoolchildren in a village endemic for Schistosoma mansoni. , 1990, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  Y. Juliano,et al.  Serum type III procollagen peptides in patients with hepatointestinal and compensated hepatoesplenic schistosomiasis forms. , 1990, Arquivos de gastroenterologia.

[28]  J. Ehrich,et al.  Sonomorphological abnormalities in Sudanese children with Schistosoma mansoni infection: a proposed staging-system for field diagnosis of periportal fibrosis. , 1989, The American journal of tropical medicine and hygiene.

[29]  P. de Caluwe,et al.  Eight years of targeted mass treatment of Schistosoma mansoni infection in Maniema, Zaire. , 1989, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[30]  G. Strickland,et al.  Characteristic sonographic pattern of schistosomal hepatic fibrosis. , 1989, The American journal of tropical medicine and hygiene.

[31]  T. Nash,et al.  Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan. , 1988, The American journal of tropical medicine and hygiene.

[32]  T. Nash,et al.  Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. , 1988, The American journal of tropical medicine and hygiene.

[33]  Z. Andrade,et al.  Pathological lesions associated with Schistosoma mansoni infection in man. , 1967, Transactions of the Royal Society of Tropical Medicine and Hygiene.